Skip to main content
Toggle navigation
Login
Search
Home
iwCLL X / Twitter
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Tweet
Stephan Stilgenbauer, MD, PhD
Department of Internal Medicine III, Ulm University, Germany
N/A
Poster(s):
1039 - The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL
2017 - Venetoclax-Obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized CLL14 study
